Cargando…
Discerning the Role of Blood Brain Barrier Dysfunction in Alzheimer’s Disease
Alzheimer’s disease (AD) is the most common form of neurodegenerative disease. The predominant characteristics of AD are the accumulation of amyloid-β (Aβ) and hyperphosphorylated tau in the brain. Blood brain barrier (BBB) dysfunction as one of the causative factors of cognitive impairment is incre...
Autores principales: | Tao, Qing-Qing, Lin, Rong-Rong, Chen, Yi-He, Wu, Zhi-Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JKL International LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9466977/ https://www.ncbi.nlm.nih.gov/pubmed/36186141 http://dx.doi.org/10.14336/AD.2022.0130-1 |
Ejemplares similares
-
The blood-brain barrier models to study apolipoprotein E genotypes in Alzheimer's disease
por: Dias, Irundika HK, et al.
Publicado: (2022) -
Is blood-brain barrier a probable mediator of non-invasive brain stimulation effects on Alzheimer’s disease?
por: Petrovskaya, Aleksandra, et al.
Publicado: (2023) -
Early Diagnosis of Alzheimer’s Disease: Moving Toward a Blood-Based Biomarkers Era
por: Tao, Qing-Qing, et al.
Publicado: (2023) -
Sortilins in the blood-brain barrier: impact on barrier integrity
por: Toth, Andrea E., et al.
Publicado: (2022) -
Detrimental Effects of ApoE ε4 on Blood–Brain Barrier Integrity and Their Potential Implications on the Pathogenesis of Alzheimer’s Disease
por: Kirchner, Kevin, et al.
Publicado: (2023)